We aim to treat patients in a precise and personalized approach. To guide personalized cancer treatment, we use state-of-the-art diagnostics and molecular imaging, including tracer-development, to select the most suitable, personalized treatment for patients, whereby the heterogeneity of the disease is taken into account in decision-making. Moreover, molecular imaging facilitates more precise surgical interventions, through integrating imaging in the operating room (OR) using specially developed tracers.

We aim to prevent or reduce the adverse side effects of cancer treatment to improve quality of life, through innovative treatments that increasingly spare normal tissues (eg. proton therapy). As part of this ambition, we aim to further connect particle research (KVI-CART) with translational and clinical research, and increase the therapeutic potential of proton therapy at the UMCG.

The Personalized Cancer Treatment program combines the following research areas:

  • innovative molecular diagnostics;
  • molecular Imaging and tracer development for analysis of disease and treatment;
  • artificial intelligence;
  • proton therapy and integration with KVI-CART.

Discover our research

More news
News
Promotion M. Metman

Redefining thyroid cancer treatment
News
Promotion B. Zapien Campos

Real-time in vivo range verification of proton therapy
News
Promotion S. Bisheshar

A cross-continental perspective of head and neck cancer, with a focus on immune biomarkers

Contact

University Medical Center Groningen (UMCG)
Institute MoHAD
Personalized Cancer Treatment
P.O. Box 196
9700 AD Groningen
The Netherlands